The expression levels of the candidate genes (HNRNPL, ELAVL1, PCBP1, PCBP2, PABPN1, PTPRF, MRPL24, DANCR, MYC, and TRPM4) were validated between tumour and normal tissue samples in TCGA-PRAD dataset. This evidence concerns the gene PCBP1 and prostate adenocarcinoma.